August 10, 2012
Nippon Kayaku and Astellas Pharma announced on August 9 that they have concluded an agreement under which Nippon Kayaku will exclusively market A670, an embolization prosthetic material for the central circulation system, in Japan. Astellas has filed an application for...read more